[Skip to Content]
[Skip to Content Landing]
Views 386
Citations 0
Viewpoint
September 26, 2019

US Food and Drug Administration Regulatory Programs for Innovative Technologies

Author Affiliations
  • 1Byers Eye Institute, Stanford, Palo Alto, California
  • 2Office of Product Evaluation and Quality, Office of Ophthalmic, Anesthesia, Respiratory and Ear, Nose, and Throat and Dental Devices, US Food and Drug Administration, Silver Spring, Maryland
JAMA Ophthalmol. Published online September 26, 2019. doi:10.1001/jamaophthalmol.2019.3708

The Center for Device and Radiologic Health at the US Food and Drug Administration (FDA) has developed several regulatory programs for innovative ophthalmic devices. The programs, which are summarized later in this article, are designed to assist in developing these technologies.

The Pre-Submission Program offers access to regulatory officials to discuss and collaborate on specific regulatory issues that an applicant might face in bringing novel technology to market. These submissions are free and can provide written and in-person feedback on questions the applicant provides to the FDA.1 The Pre-Submission Program can identify issues early, often before any formal submissions are made, and help guide the development of nonclinical and clinical work. Additionally, applicants benefit from the accumulated institutional knowledge of the FDA, which can lead to efficient data generation and regulatory pathways, ultimately helping to bring devices to patients sooner.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×